Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907361 · ClinicalTrials.gov registry record
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
A clinical trial of Need for MRI Imaging With Pacemaker or and Implantable Cardioverter Defibrillator Implanted, sponsored by Scripps Health.
- Completed
- Registry status
- 2,039
- Enrollment target
- 20
- Study locations
NCT00907361: Completed study of Need for MRI Imaging With Pacemaker or and Implantable Cardioverter Defibrillator Implanted, sponsored by Scripps Health.
NCT00907361 is a study of Need for MRI Imaging With Pacemaker or and Implantable Cardioverter Defibrillator Implanted that has completed, run by Scripps Health. The registered enrollment target is 2,039 participants. The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00907361, a study of Need for MRI Imaging With Pacemaker or and Implantable Cardioverter Defibrillator Implanted, has completed, sponsored by Scripps Health.
- COMPLETED
- Registry status
- 2,039 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will create a registry of patients with pacemakers and implantable ICDs who will undergo clinically indicated MRI and will document the incidence of any adverse events or changes in device parameters that might be associated with the procedure.
Conditions Studied
Interventions
- DEVICE MRI with pacemaker or ICD
Study Locations (20)
California
- Providence St. Joseph Medical Center - Burbank
- Scripps Clinic/Green Hospital - La Jolla
- Scripps Memorial Hospital - La Jolla
- UCLA Cardiac Arrhythmia Center - Los Angeles
- Spectrum Clinical Research - Moreno Valley
- University of California, San Diego - San Diego
Pennsylvania
- Abington Health System - Abington
- Allegheny General Hospital - Pittsburgh
Connecticut
- Yale University School of Medicine - New Haven
Florida
- Aventura Hospital and Medical Center - Aventura
Indiana
- Northern Indiana Research Alliance - Fort Wayne
Kentucky
- Baptist Health Lexington - Lexington
Michigan
- Providence Heart Institute - Southfield
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,039 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-06 |
What the finished NCT00907361 record still lists
NCT00907361 is an observational study that tracks outcomes without assigning an intervention. Its 2,039 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Need for MRI Imaging With Pacemaker or appearing as the primary indexed condition, and to 1 intervention - of which MRI with pacemaker or ICD is the first listed.
NCT00907361 names 20 study sites across 14 states, led by California, Pennsylvania, Connecticut.
Frequently Asked Questions
What is clinical trial NCT00907361 about?
NCT00907361 is a clinical study titled "The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)". This study will create a registry of patients with pacemakers and implantable ICDs who will undergo clinically indicated MRI and will document the incidence of any adverse events or changes in device parameters that might be associated with the procedure.
What is the current status of trial NCT00907361?
This trial is currently completed. The enrollment target is 2,039 participants. The study started on 2009-04. Estimated completion is 2014-06.
What conditions does trial NCT00907361 study?
This clinical trial studies the following conditions: Need for MRI Imaging With Pacemaker or, Implantable Cardioverter Defibrillator Implanted.
What interventions are being tested in trial NCT00907361?
The interventions under investigation include: MRI with pacemaker or ICD (DEVICE).
Who is sponsoring clinical trial NCT00907361?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00907361 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia